+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Pathology Instruments - Global Strategic Business Report

  • PDF Icon

    Report

  • 597 Pages
  • April 2025
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5140081
The global market for Pathology Instruments was valued at US$4.5 Billion in 2024 and is projected to reach US$6.2 Billion by 2030, growing at a CAGR of 5.6% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Pathology Instruments market.

Global Pathology Instruments Market - Key Trends & Drivers Summarized

What Are Pathology Instruments and Their Uses?

Pathology instruments are essential tools used in the diagnosis and study of diseases. These instruments include microscopes, tissue processors, slide strainers, and digital pathology systems. They are employed in clinical laboratories, research institutions, and hospitals to analyze biological samples, such as blood, tissues, and bodily fluids, to detect abnormalities and understand disease mechanisms. Pathology instruments play a crucial role in various medical fields, including oncology, hematology, and microbiology, providing critical insights that guide treatment decisions and improve patient outcomes.

How Are Technological Advancements Shaping This Market?

Technological advancements are significantly shaping the pathology instruments market. The development of digital pathology systems, which allow for the scanning, storage, and analysis of pathology slides, is revolutionizing the field. These systems enhance diagnostic accuracy, facilitate remote consultations, and enable easier sharing of data. Advances in imaging technologies, such as high-resolution and confocal microscopy, are improving the visualization of cellular structures and pathological changes. Additionally, the integration of artificial intelligence and machine learning algorithms in pathology instruments is enhancing diagnostic capabilities, enabling the automated analysis of complex data and the identification of patterns that may be missed by human eyes.

What Role Do Market Demands Play in This Industry?

Market demands are driving significant changes in the pathology instruments market. The rising prevalence of chronic diseases and cancer is increasing the need for accurate and timely diagnostics, boosting demand for advanced pathology instruments. The shift towards personalized medicine, which requires detailed molecular and genetic analysis, is also influencing the development and adoption of innovative pathology tools. The expanding geriatric population, with its higher incidence of various diseases, further fuels the need for sophisticated diagnostic instruments. Moreover, the increasing focus on early disease detection and preventive healthcare is prompting laboratories and healthcare facilities to invest in cutting-edge pathology instruments.

What Factors Are Driving Market Growth?

The growth in the pathology instruments market is driven by several factors, including the rising incidence of chronic and infectious diseases, advancements in diagnostic technologies, and increasing healthcare expenditure. The demand for precise and early diagnostic tools is propelling market growth, as early detection can significantly improve treatment outcomes. Technological innovations, such as digital pathology and AI-driven diagnostic tools, are enhancing the efficiency and accuracy of disease diagnosis. Additionally, the growing trend towards personalized medicine is driving the need for advanced pathology instruments that can provide detailed molecular and genetic insights. The expansion of healthcare infrastructure in emerging markets, along with government initiatives to improve diagnostic capabilities, is also contributing to the market's growth. These factors collectively ensure a robust demand for pathology instruments, driving the market forward.

Report Scope

The report analyzes the Pathology Instruments market, presented in terms of units. The analysis covers the key segments and geographic regions outlined below.

Segments: ETechnology (Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry, Other Technologies); End-Use (Diagnostics, Drug Discovery, Other End-Uses).

Geographic Regions/Countries: World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Molecular Diagnostics segment, which is expected to reach US$1.7 Billion by 2030 with a CAGR of a 7.1%. The Immunoassays Technology segment is also set to grow at 5.2% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $1.7 Billion in 2024, and China, forecasted to grow at an impressive 9.3% CAGR to reach $603.8 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Pathology Instruments Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Pathology Instruments Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Pathology Instruments Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Agilent Technologies, Inc., Becton, Dickinson and Company, Bio SB, Bio-Rad Laboratories, Inc., Danaher Corporation and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 114 companies featured in this Pathology Instruments market report include:

  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio SB
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Hamamatsu Photonics K.K
  • Mikroscan Technologies, Inc.
  • PerkinElmer Inc.
  • PHC Holdings Corporation
  • Roche Diagnostics Corporation

Tariff Impact Analysis: Key Insights for 2025

Global tariff negotiations across 180+ countries are reshaping supply chains, costs, and competitiveness. This report reflects the latest developments as of April 2025 and incorporates forward-looking insights into the market outlook.

The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.

What’s Included in This Edition:

  • Tariff-adjusted market forecasts by region and segment
  • Analysis of cost and supply chain implications by sourcing and trade exposure
  • Strategic insights into geographic shifts

Buyers receive a free July 2025 update with:

  • Finalized tariff impacts and new trade agreement effects
  • Updated projections reflecting global sourcing and cost shifts
  • Expanded country-specific coverage across the industry

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Pathology: The Silent Pillar of Modern Medicine's Evolution
  • Global Economic Update
  • EXHIBIT:Global Average Annual Brent Crude Oil Price (In US$ Per Barrel) for Years 2017 through 2024
  • Global Inflation Rates (In %) for the Years 2019 through 2024
  • World Economic Growth Projections (Real GDP, Annual % Change) for the Years 2020 Through 2024
  • Global Number of Unemployed People (In Million) for Years 2019 Through 2024
  • Competition
  • Pathology Instruments - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rise in Chronic/Infectious Diseases Drives Demand for Pathology Instruments in Clinical Chemistry & Diagnostics
  • Rising Prevalence of Chronic/Infectious Diseases Drives Demand for Pathology Instruments & Devices Powering Modern Diagnostics: Global Cost of Chronic Diseases (In US$ Trillion) for the Years 2023, 2025, 2027, 2029 and 2031
  • Global Investments in Health Systems to Benefit Market Growth
  • Rise of Molecular Diagnostics to Drive a Large Chunk of Growth in the Pathology Instruments Market
  • Robust Growth of Molecular Diagnostics Services Expands the Opportunity Avenue for Pathology Instruments: Global Market for Molecular Diagnostics (In US$ Million) for Years 2023, 2025 and 2027
  • Growing Role of Pathology in Drug Development to Spur Demand for Pathology Instruments
  • From Microscope to Market, Pathology's Pivotal Role in Drug Evolution Cannot be Undermined: Global Market for Drug Discovery (In US$ Billion) for Years 2023, 2025, 2027, 2029 and 2031
  • Rising Importance of Forensic Pathology to Spur Demand for Pathology Instruments
  • Growing Demand for Forensic Technologies & Services Translates Directly into Increased Sales of Pathology Instruments: Global Market for Forensic Technologies & Services (In US$ Million) for Years 2023, 2025, 2027 and 2029
  • Immunoassays Remain the Technology of Choice in the Field of Pathology
  • Impact of AI on Pathology Instruments
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Pathology Instruments Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • Table 2: World Recent Past, Current & Future Analysis for Pathology Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 3: World Historic Review for Pathology Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 4: World 15-Year Perspective for Pathology Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • Table 5: World Recent Past, Current & Future Analysis for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 6: World Historic Review for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 7: World 15-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 8: World Recent Past, Current & Future Analysis for Immunoassays Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 9: World Historic Review for Immunoassays Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 10: World 15-Year Perspective for Immunoassays Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 11: World Recent Past, Current & Future Analysis for Microbiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 12: World Historic Review for Microbiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 13: World 15-Year Perspective for Microbiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 14: World Recent Past, Current & Future Analysis for Clinical Chemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 15: World Historic Review for Clinical Chemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 16: World 15-Year Perspective for Clinical Chemistry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 17: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 18: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 19: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 20: World Recent Past, Current & Future Analysis for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 21: World Historic Review for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 22: World 15-Year Perspective for Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 23: World Recent Past, Current & Future Analysis for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 24: World Historic Review for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 25: World 15-Year Perspective for Drug Discovery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 28: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Pathology Instruments Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • Table 29: USA Recent Past, Current & Future Analysis for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 30: USA Historic Review for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 31: USA 15-Year Perspective for Pathology Instruments by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies for the Years 2015, 2025 & 2030
  • Table 32: USA Recent Past, Current & Future Analysis for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 33: USA Historic Review for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 34: USA 15-Year Perspective for Pathology Instruments by End-Use - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery and Other End-Uses for the Years 2015, 2025 & 2030
CANADA
  • Table 35: Canada Recent Past, Current & Future Analysis for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 36: Canada Historic Review for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 37: Canada 15-Year Perspective for Pathology Instruments by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies for the Years 2015, 2025 & 2030
  • Table 38: Canada Recent Past, Current & Future Analysis for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 39: Canada Historic Review for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 40: Canada 15-Year Perspective for Pathology Instruments by End-Use - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery and Other End-Uses for the Years 2015, 2025 & 2030
JAPAN
  • Pathology Instruments Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • Table 41: Japan Recent Past, Current & Future Analysis for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 42: Japan Historic Review for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 43: Japan 15-Year Perspective for Pathology Instruments by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies for the Years 2015, 2025 & 2030
  • Table 44: Japan Recent Past, Current & Future Analysis for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 45: Japan Historic Review for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 46: Japan 15-Year Perspective for Pathology Instruments by End-Use - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery and Other End-Uses for the Years 2015, 2025 & 2030
CHINA
  • Pathology Instruments Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • Table 47: China Recent Past, Current & Future Analysis for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 48: China Historic Review for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 49: China 15-Year Perspective for Pathology Instruments by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies for the Years 2015, 2025 & 2030
  • Table 50: China Recent Past, Current & Future Analysis for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 51: China Historic Review for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 52: China 15-Year Perspective for Pathology Instruments by End-Use - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery and Other End-Uses for the Years 2015, 2025 & 2030
EUROPE
  • Pathology Instruments Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • Table 53: Europe Recent Past, Current & Future Analysis for Pathology Instruments by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 54: Europe Historic Review for Pathology Instruments by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 55: Europe 15-Year Perspective for Pathology Instruments by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • Table 56: Europe Recent Past, Current & Future Analysis for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 57: Europe Historic Review for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 58: Europe 15-Year Perspective for Pathology Instruments by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies for the Years 2015, 2025 & 2030
  • Table 59: Europe Recent Past, Current & Future Analysis for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 60: Europe Historic Review for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 61: Europe 15-Year Perspective for Pathology Instruments by End-Use - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery and Other End-Uses for the Years 2015, 2025 & 2030
FRANCE
  • Table 62: France Recent Past, Current & Future Analysis for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 63: France Historic Review for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 64: France 15-Year Perspective for Pathology Instruments by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies for the Years 2015, 2025 & 2030
  • Table 65: France Recent Past, Current & Future Analysis for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 66: France Historic Review for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 67: France 15-Year Perspective for Pathology Instruments by End-Use - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery and Other End-Uses for the Years 2015, 2025 & 2030
GERMANY
  • Table 68: Germany Recent Past, Current & Future Analysis for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 69: Germany Historic Review for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 70: Germany 15-Year Perspective for Pathology Instruments by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies for the Years 2015, 2025 & 2030
  • Table 71: Germany Recent Past, Current & Future Analysis for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 72: Germany Historic Review for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 73: Germany 15-Year Perspective for Pathology Instruments by End-Use - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery and Other End-Uses for the Years 2015, 2025 & 2030
ITALY
  • Table 74: Italy Recent Past, Current & Future Analysis for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 75: Italy Historic Review for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 76: Italy 15-Year Perspective for Pathology Instruments by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies for the Years 2015, 2025 & 2030
  • Table 77: Italy Recent Past, Current & Future Analysis for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 78: Italy Historic Review for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 79: Italy 15-Year Perspective for Pathology Instruments by End-Use - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery and Other End-Uses for the Years 2015, 2025 & 2030
UNITED KINGDOM
  • Table 80: UK Recent Past, Current & Future Analysis for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 81: UK Historic Review for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 82: UK 15-Year Perspective for Pathology Instruments by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies for the Years 2015, 2025 & 2030
  • Table 83: UK Recent Past, Current & Future Analysis for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 84: UK Historic Review for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 85: UK 15-Year Perspective for Pathology Instruments by End-Use - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery and Other End-Uses for the Years 2015, 2025 & 2030
SPAIN
  • Table 86: Spain Recent Past, Current & Future Analysis for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 87: Spain Historic Review for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 88: Spain 15-Year Perspective for Pathology Instruments by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies for the Years 2015, 2025 & 2030
  • Table 89: Spain Recent Past, Current & Future Analysis for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 90: Spain Historic Review for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 91: Spain 15-Year Perspective for Pathology Instruments by End-Use - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery and Other End-Uses for the Years 2015, 2025 & 2030
RUSSIA
  • Table 92: Russia Recent Past, Current & Future Analysis for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 93: Russia Historic Review for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 94: Russia 15-Year Perspective for Pathology Instruments by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies for the Years 2015, 2025 & 2030
  • Table 95: Russia Recent Past, Current & Future Analysis for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 96: Russia Historic Review for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 97: Russia 15-Year Perspective for Pathology Instruments by End-Use - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery and Other End-Uses for the Years 2015, 2025 & 2030
REST OF EUROPE
  • Table 98: Rest of Europe Recent Past, Current & Future Analysis for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 99: Rest of Europe Historic Review for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 100: Rest of Europe 15-Year Perspective for Pathology Instruments by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies for the Years 2015, 2025 & 2030
  • Table 101: Rest of Europe Recent Past, Current & Future Analysis for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 102: Rest of Europe Historic Review for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 103: Rest of Europe 15-Year Perspective for Pathology Instruments by End-Use - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery and Other End-Uses for the Years 2015, 2025 & 2030
ASIA-PACIFIC
  • Table 104: Asia-Pacific Recent Past, Current & Future Analysis for Pathology Instruments by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • Table 105: Asia-Pacific Historic Review for Pathology Instruments by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 106: Asia-Pacific 15-Year Perspective for Pathology Instruments by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • Table 107: Asia-Pacific Recent Past, Current & Future Analysis for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 108: Asia-Pacific Historic Review for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 109: Asia-Pacific 15-Year Perspective for Pathology Instruments by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies for the Years 2015, 2025 & 2030
  • Table 110: Asia-Pacific Recent Past, Current & Future Analysis for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • Table 111: Asia-Pacific Historic Review for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • Table 112: Asia-Pacific 15-Year Perspective for Pathology Instruments by End-Use - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery and Other End-Uses for the Years 2015, 2025 & 2030
AUSTRALIA
INDIA
  • Pathology Instruments Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
SOUTH KOREAREST OF ASIA-PACIFICLATIN AMERICAARGENTINABRAZILMEXICOREST OF LATIN AMERICAMIDDLE EASTIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTAFRICAIV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio SB
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Hamamatsu Photonics K.K
  • Mikroscan Technologies, Inc.
  • PerkinElmer Inc.
  • PHC Holdings Corporation
  • Roche Diagnostics Corporation

Table Information